👤 Wenqi Li

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
3991
Articles
2551
Name variants
Also published as: Xiaocun Li, Jianyu Li, Xinzhi Li, Guanqiao Li, Zequn Li, Guang-Xi Li, Yubo Li, Bugao Li, Qingchao Li, Xikun Li, Hong-Tao Li, Guobin Li, Xihao Li, Rongqing Li, Chang-Da Li, Meng-Yue Li, DaZhuang Li, Shunqin Li, Jiajie Li, Yaqiong Li, Yuan-hao Li, Yongmei Li, X Y Li, Peilin Li, Ran Li, Chunshan Li, Yixiang Li, Guanglve Li, Ye Li, Zili Li, Yihao Li, Qing Run Li, Liling Li, Meng-Yang Li, Ziyun Li, Jun-Ying Li, Xinhai Li, Yongjiang Li, Wanru Li, Wenhao Li, Shisheng Li, Sai Li, Guangwen Li, Hua Li, Dongmei Li, Jiayang Li, Zunjiang Li, Minglong Li, Wenzhe Li, Zihan Li, Jin-Long Li, Hongxin Li, Caiyu Li, Fa-Hui Li, Guangpu Li, Teng Li, Wen-Jie Li, Hegen Li, Ang Li, Zhizong Li, Lu-Yun Li, Peng Li, Shiyu Li, Fang Li, Jiuke Li, Miyang Li, Mingxu Li, Chen-Xi Li, Panlong Li, Changwei Li, Biyu Li, Yaoqi Li, San-Feng Li, Jiaming Li, Jiyuan Li, Rongkai Li, Yani Li, Linke Li, C Y Li, Thomas Li, Siting Li, Yongnan Li, Jinchen Li, Jin-Ping Li, Xuewen Li, R Li, Xianlong Li, Aixin Li, Xuening Li, Guang Li, Xiaoming Li, Z-H Li, Yongli Li, Baohong Li, Shuyuan Li, L Li, Yuanmei Li, Yanwu Li, Hualing Li, Sibing Li, Xining Li, Qinghe Li, Zonghua Li, Liqin Li, Jingya Li, Youjun Li, Zheng-Dao Li, Zhenshu Li, Heng-Zhen Li, Yuhui Li, Wen-Ying Li, Wei Li, Shuanglong Li, Fei-feng Li, Letai Li, Kangli Li, Ming Li, Wenbo Li, Runwen Li, Yarong Li, Weidong Li, S E Li, Xin-Tao Li, Ruotong Li, Shuguang Li, Xiuzhen Li, Lingxi Li, Chuan-Hai Li, Tingting Li, Guanghua Li, Zhongyu Li, Zhen-Yu Li, Deyu Li, Hansen Li, Jinzhi Li, Yijing Li, Kaifeng Li, Wen-Xing Li, Qintong Li, Naishi Li, Xin-Ping Li, Han-Ni Li, Jiaying Li, Cui-lan Li, Ruonan Li, Jun-Jie Li, Shuhao Li, Ruitong Li, Suyan Li, Gen-Lin Li, Dianjie Li, Junhui Li, Ya-Jun Li, Xue Cheng Li, Ding-Biao Li, Xiying Li, Yansong Li, Weiyong Li, Xinyang Li, Cui Li, Xiaoyong Li, Y L Li, Xueyi Li, Jingxiang Li, Wenxue Li, Jianglin Li, Yingpu Li, Yan-Hua Li, Jing-Yao Li, Shawn Shun-Cheng Li, Xiao-Min Li, Wan Jie Li, Ya-Ting Li, Dongbiao Li, Keguo Li, Yuanfei Li, Longhui Li, Jing-Yi Li, Zhonghua Li, Chunyi Li, Peiyun Li, Qinglan Li, Yue-Ting Li, Da Li, YiPing Li, Demin Li, Haipeng Li, Chuan Li, Ze-An Li, Jianmin Li, Minhui Li, Yu Li, Yiwei Li, Xiangzhe Li, Minglun Li, Xue-Min Li, Kenneth Kai Wang Li, Chunlan Li, Chiyang Li, Hulun Li, Juan-Juan Li, Hua-Zhong Li, Jiaomei Li, Xiangyun Li, Jing Li, Yingshuo Li, Baixing Li, Dengke Li, Qingling Li, Rui-Han Li, Dong Li, Xiaoxia Li, Dezhi Li, Sheng-Jie Li, Ying-Qing Li, Xin-Jian Li, Guangxi Li, Yanhui Li, Sha-Sha Li, Mengxuan Li, Ziyu Li, Gang Li, Panyuan Li, Hong-Wen Li, Xiaojuan Li, Dongnan Li, Huaiyuan Li, Ji-Liang Li, Huaping Li, C H Li, Bohua Li, Pei-Ying Li, Shaobin Li, Ronald Li, Shilun Li, Shi-Hong Li, John Zhong Li, Xinyu Li, Lujiao Li, Song-Chao Li, Chenghong Li, Baohua Li, Nianfu Li, Jun-Cheng Li, Yimeng Li, Chunting Li, Chien-Feng Li, Mei-Zhen Li, Zhengjie Li, Liwei Li, Yan-Yan Li, Huijun Li, Chengyun Li, Lijun Li, Hening Li, Fengxia Li, Jialing Li, Xin Li, Ningyan Li, Zhenghui Li, Ailing Li, Chaochen Li, Tengyan Li, Xianlu Li, Jiaqi Li, Jiabei Li, Wenjing Li, Jingshu Li, Han-Bo Li, Zengyang Li, Chunyan Li, Runzhen Li, Xi-Hai Li, Xuezhong Li, MengGe Li, Pei-Lin Li, Wan-Xin Li, Ruobing Li, Ning Li, Meitao Li, Xia Li, Ziqiang Li, Wen-Xi Li, Shenghao Li, Hehua Li, Yucheng Li, Dujuan Li, Yuying Li, Shaofei Li, Shaoguang Li, Min-Rui Li, Shuqiang Li, Dan C Li, Huashun Li, Ganggang Li, Haoqi Li, Handong Li, Yan-Nan Li, Xianglong Li, Jing-Jing Li, Songhan Li, Conglin Li, Qingli Li, Miao Li, Chenyu Li, Ke Li, Zhen-Hua Li, Chuan-Yun Li, Gaoyuan Li, Youming Li, Qingrun Li, Dong-Yun Li, Shuangfei Li, Fengfeng Li, Qinggang Li, Huixia Li, Xingye Li, Xiangjun Li, Huiying Li, Xingyu Li, Zhaoping Li, Wenying Li, Honghui Li, Cheung Li, Xuelian Li, Zhenming Li, Changyan Li, Mulin Jun Li, Shangjia Li, Jingjing Li, Suhong Li, Xinping Li, Siyu Li, Guangzhen Li, Xiangyan Li, Shiyun Li, Xiaoyu Li, Yaobo Li, Xuewang Li, Mei Li, Manjiang Li, Wan Li, Xiao-Li Li, Xiaoya Li, Shan Li, Shitao Li, Zehan Li, Lijia Li, Huiliang Li, Chunqiong Li, Junjun Li, Hui-Long Li, Zhao-Cong Li, Zhi-Wei Li, Wenxi Li, Chang-hai Li, Yuqiu Li, Xue-Yan Li, Yuan-Yuan Li, Xiang-Jun Li, Chia Li, Y X Li, Yunyun Li, Zhen-Jia Li, Qiuxuan Li, De-Jun Li, Keqing Li, Junxian Li, Shuwen Li, Lingjun Li, Deheng Li, Si-Xing Li, Yaodong Li, Shigang Li, Gao-Fei Li, Minle Li, Le-Le Li, Ziwen Li, Yongqiu Li, Pu-Yu Li, Nan-Nan Li, Lan-Lan Li, Hongming Li, Shuang Li, Wanting Li, Gong-Hua Li, Zhengyu Li, Weiguang Li, Guoqing Li, Xiaomeng Li, Yuanze Li, Yunqi Li, Yuandong Li, Changcheng Li, Shiyue Li, Hanbo Li, Yinggao Li, Dingshan Li, Linlin Li, Jin-Wei Li, Cheng-Tian Li, Yaxi Li, Wei-Ming Li, Ming-Han Li, Wenchao Li, Guangyan Li, Zhaosha Li, Xuesong Li, Chun-Quan Li, Yongzhen Li, Tao Li, Xiankai Li, Yaxuan Li, Tian-wang Li, Yuchan Li, Jiaxi Li, Yalin Li, Pei-Zhi Li, Guanyu Li, Jinlan Li, Huizi Li, Jianping Li, Yun-Lin Li, Yadong Li, Sujing Li, Wenzhuo Li, Xuri Li, Mengqiu Li, Yun Li, Ling-Ling Li, Chengwen Li, Shu-Feng Li, Haojing Li, Zhiyu Li, Ziyang Li, Yaochen Li, Qian Li, Bohao Li, Wenyang Li, Wenming Li, Mingxuan Li, Bingsong Li, Anqi Li, Shuai Li, Xiaoju Li, Na Li, Huibo Li, Chuanfang Li, Pengsong Li, Ruotian Li, Chunya Li, En-Min Li, Zong-Xue Li, Yan Ning Li, Honglin Li, Min-jun Li, Jinhua Li, Qian-Qian Li, Yuanheng Li, Chunxiao Li, Shijun Li, Kuan Li, Baoguang Li, Jie-Shou Li, Zimeng Li, Mengmeng Li, W-B Li, Binkui Li, Yu-Sheng Li, Junjie Li, Xiaoqi Li, Xiucui Li, Haihua Li, Yu-Lin Li, Tsai-Kun Li, Shujing Li, Mengyun Li, Mingna Li, Lanlan Li, Moyi Li, Xiyun Li, Ya-Pei Li, Zhongjie Li, Zhenbei Li, Shuangshuang Li, Hongwei Li, Ding-Jian Li, Xiao-Qiang Li, Danni Li, Min Li, Pengyang Li, Kun-Xin Li, Xiangpan Li, Zesong Li, Mingfei Li, Shuwei Li, Mingdan Li, Xihe Li, Jianfeng Li, Dexiong Li, Rongsong Li, Yinxiong Li, Hong-Yu Li, Weijian Li, Changhui Li, Dechao Li, Wenxia Li, Guoxiang Li, Ziru Li, Juxue Li, Man Li, Huayin Li, Xiao-yu Li, Jianyi Li, Guowei Li, Xingya Li, Gongda Li, Yajun Li, Wei-Ping Li, Nanjun Li, P H Li, Ranran Li, Suping Li, Jason Li, Monica M Li, Xianlun Li, Qi Li, Xiaoli Li, Xionghui Li, Fei Li, Hongmei Li, Xu-Wei Li, Mengsen Li, Quanpeng Li, Yajiao Li, Qilan Li, Qiuhong Li, Zongyun Li, Xiao-Yun Li, Cheng-Lin Li, Yousheng Li, Wen-Ting Li, Guoping Li, A Li, Simin Li, Weiguo Li, Xue-Nan Li, Xiaoying Li, Shengsheng Li, Hong Li, Yuqi Li, Zihua Li, Qing Li, Jiaping Li, Weiyang Li, Feng Li, Peihong Li, Jin-Mei Li, Lisha Li, Cuicui Li, Kaibo Li, Hanbing Li, Meng-Hua Li, J T Li, Xiangwei Li, Baiqiang Li, Ziliang Li, Donghe Li, Zheng Li, Congfa Li, Wenrui Li, Yong Li, Xiuling Li, Jingqi Li, Zhiyong Li, Xiao-Kang Li, Hanqi Li, Yangyang Li, Dongfang Li, Zhuorong Li, X-H Li, Dong Sheng Li, Lan-Juan Li, Xianrui Li, Zhigao Li, Chenlin Li, Zihui Li, Guoli Li, Huanqiu Li, Zhan Li, Weisong Li, Xinglong Li, Xiaozhen Li, Zhiyang Li, Cunxi Li, Ying Li, Jianlin Li, Yanshu Li, Guiying Li, Jinku Li, Cuiling Li, Zhisheng Li, Changgui Li, Xuekun Li, Yuguang Li, Wenke Li, Jiayi Li, Suwen Li, Peihua Li, Chang-Ping Li, Guangda Li, Jieming Li, Chunhui Li, Tongyao Li, Peiyu Li, Linfeng Li, Yuzhe Li, Qifang Li, Chang-Yan Li, Xiaolin Li, Duanxiang Li, Vivian Li, Justin Li, Meiting Li, Xue-Er Li, Hongchang Li, Youwei Li, Ronggui Li, Xingwang Li, Tiange Li, Yongjia Li, Dacheng Li, Xinmin Li, Luquan Li, Guoxing Li, Jianyong Li, Zongchao Li, Jia Li, Haimin Li, Sheng-Qing Li, Lingjie Li, Yiwen Li, Baoqi Li, Leyao Li, Xiao-Qin Li, Jiajing Li, Yanlin Li, Liao-Yuan Li, Yongkai Li, Hangwen Li, Hengguo Li, An-Qi Li, Xuehua Li, AnHai Li, Chenli Li, Zhengrui Li, Rumei Li, Yan-Yu Li, Lipeng Li, Qinqin Li, Qinghua Li, Leilei Li, Lianyong Li, Zhou Li, Q Li, Bizhi Li, Cheng-Wei Li, Wenwen Li, Jian'an Li, Guangqiang Li, Sichong Li, Wenyi Li, Qing-Min Li, Meiyan Li, Yun-Da Li, Jian-Qiang Li, Yingrui Li, Chenfeng Li, Shen Li, Ziqi Li, Yunfeng Li, Shufen Li, Yueqi Li, Xiao-Guang Li, Jiali Li, Zhencheng Li, Qiufeng Li, Pinghua Li, Xu Li, Zhenli Li, Yunxiao Li, Rosa J W Li, Hsin-Yun Li, XiaoQiu Li, Zhankui Li, Zhi Li, Zhijie Li, Huimin Li, Ruifang Li, Xiao-xu Li, Man-Xiang Li, Cong Li, Chengbin Li, Yuping Li, G Li, Zhi-Yong Li, Yukun Li, Xiong Bing Li, Wen Lan Li, Qingjie Li, Han Li, Yutang Li, Hankun Li, Hongling Li, Zhifan Li, Yan-Guang Li, Ji-Min Li, Peipei Li, Tian-Yi Li, Zhihao Li, Yao Li, Zheyun Li, Zhonglin Li, Lin Li, Jinfang Li, Chenjie Li, Yanming Li, S L Li, Ben-Shang Li, Hong-Lan Li, Xionghao Li, Shunqing Li, Ming-Kai Li, Lan Li, Yanwei Li, Chien-Te Li, Wenyan Li, Xiaoheng Li, Zeyuan Li, Hongqin Li, Zhenhao Li, Jonathan Z Li, Yong-Liang Li, M Li, Jiehan Li, Hongguo Li, Chenxin Li, Yongsen Li, Qingyun Li, Pengyu Li, Ai-Qin Li, Zichao Li, Cien Li, Qingyu Li, Xijing Li, Jingshang Li, Xingyuan Li, Dehua Li, Yanjiao Li, Jia-Huan Li, Guoxi Li, Xudong Li, Xingfang Li, Jisheng Li, Rongyao Li, Ru Li, Jiangya Li, Yiche Li, Yilang Li, Yunshen Li, Jingchun Li, Hexin Li, H J Li, Yanping Li, Qing-Wei Li, Qiang Li, Hsiao-Hui Li, L I Li, Hongzheng Li, Laiqing Li, Ningyang Li, Zhongxia Li, Guangquan Li, Shun Li, Hui-Jun Li, Xuefei Li, Guojun Li, Hung Li, Senlin Li, Jinping Li, Sainan Li, Jinghui Li, Zulong Li, Chengsi Li, P Li, Fulun Li, Yonghao Li, Mingli Li, Yehong Li, Pei Li, Quanshun Li, Yongping Li, Liguo Li, Weimin Li, Mingxia Li, Xue-Hua Li, M V Li, Gan Li, Shichao Li, Dapei Li, Zejian Li, Lihong Li, Haixia Li, Jingmei Li, Ao Li, Yitong Li, Siwen Li, Yanlong Li, Zhao Li, Kui Li, Yunxu Li, Xuanfei Li, Zilin Li, Mingqiang Li, Xiaojiao Li, Yinzhen Li, Yunsheng Li, Li-Min Li, Xiangqi Li, Jia-Peng Li, Haibo Li, Xiao-Jun Li, Yan-Hong Li, Shi Li, Xueling Li, Conghui Li, Xiaoxiong Li, Wanni Li, Chitao Li, Haiyang Li, Xiaobai Li, Pingping Li, Mingquan Li, Suran Li, Yuanfang Li, Yingqin Li, Qiner Li, Jiafang Li, Shanhang Li, Han-Bing Li, Zongzhe Li, Yikang Li, Si-Yuan Li, Hongmin Li, Caihong Li, Yajing Li, Benyi Li, Yuquan Li, Hongzhi Li, Chengxin Li, Xiaojiaoyang Li, Xinxin Li, Jian-Shuang Li, Yubin Li, Dazhi Li, Chenglan Li, Yuhong Li, Fengqiao Li, Di Li, Yanbing Li, Jufang Li, Zecai Li, Qipei Li, Xiaoning Li, Xiyue Li, Minghua Li, Tianchang Li, Zhuoran Li, Hongru Li, Shiqi Li, Mei-Ya Li, Wuyan Li, Yi-Ling Li, Yingjian Li, Zhirong Li, Wang Li, Mingyang Li, Weijun Li, Boyang Li, Cai Li, Jingcheng Li, Ivan Li, Mengshi Li, Manxia Li, Ya Li, Dan-Ni Li, Wen-Chao Li, Sunan Li, Zhencong Li, Lai K Li, Jiong Li, Daiyue Li, Bingong Li, Chunxue Li, Yunlong Li, Jianshuang Li, Juanling Li, Xinbin Li, Xue-jing Li, Yuling Li, Yetian Li, Xianlin Li, Chuangpeng Li, Mingrui Li, Yanjun Li, Jiequn Li, Zhongding Li, Jiangui Li, Zhengyang Li, Cyril Li, Xinghui Li, Yuefei Li, Xinyan Li, Xiaoyun Li, Yushan Li, Ping'an Li, Weiping Li, Huan Li, Changjiang Li, Chengping Li, He-Zhen Li, G-P Li, Yinliang Li, Wen Li, Weihai Li, Yu-Kun Li, Jiangan Li, Zhaojin Li, Bingxin Li, Wenjuan Li, Chia-Yang Li, Wenyu Li, Hairong Li, Su Li, Mei-Lan Li, Wenjun Li, Jiaxin Li, Chenguang Li, Ming D Li, Ruyue Li, Xiaolian Li, Ya-Ge Li, Yinyan Li, Guangli Li, Rujia Li, Qijun Li, Lixia Li, Yunrui Li, Yuhuang Li, Shanshan Li, Wan-Shan Li, Jing-gao Li, Yiyang Li, Fengxiang Li, Nana Li, Jingui Li, Huamao Li, Xiankun Li, Jingke Li, Tianyao Li, Xiaowei Li, Junming Li, Hai-Yun Li, Zhongxian Li, H-J Li, Zhixiong Li, Lingyan Li, Xuhang Li, Chen-Lu Li, Jialun Li, Xinjian Li, Zilu Li, Sheng-Fu Li, Zezhi Li, Xue-Fei Li, Yudong Li, Hongjiang Li, Jingyun Li, Binghua Li, Hanjun Li, Qihua Li, Jin-Qiu Li, Jiaxuan Li, Guangjin Li, Xutong Li, Ranwei Li, Kai Li, Wei-Li Li, Keanning Li, Ling Li, Peiqin Li, Xiaodong Li, Nanxing Li, Qihang Li, Baoguo Li, Jianrong Li, Zhehui Li, Chenghao Li, Weike Li, Chuanbao Li, Zhixuan Li, Chuzhong Li, M D Li, Yuan-Tao Li, Kening Li, Guilan Li, Wanshi Li, Ling-Zhi Li, Hengtong Li, Yifan Li, Ya-Li Li, Songyun Li, Xiaoran Li, Bolun Li, Linchuan Li, Jiachen Li, Haibin Li, Huangbao Li, Guo-Chun Li, Xinli Li, S Li, Wenqing Li, Wenhua Li, Caiyun Li, Xinrui Li, Hanbin Li, Wanwan Li, Jia Li Li, Wan-Hong Li, Mingke Li, Huanhuan Li, Xiaoyuan Li, Zongfang Li, Yang Li, BoWen Li, Duoyun Li, Yimei Li, Zhi-qiang Li, Yi-Ting Li, Jiangxia Li, Yujie Li, Zhiping Li, Yan-Li Li, Haiming Li, Gaijie Li, Yuemei Li, Xuefeng Li, Xiao-Hong Li, Mengjuan Li, Yinglin Li, Yaofu Li, Ren-Ke Li, Yi Li, Baosheng Li, Mian Li, Yujun Li, Lixi Li, Jin-Xiu Li, Jiwen Li, Zhouhua Li, Qingqin S Li, Honglei Li, Guojin Li, Xin-Yue Li, Dingchen Li, Xiaoling Li, Meng-Jun Li, Peining Li, Congjiao Li, Huilin Li, Songtao Li, Fusheng Li, Dai Li, Meiyue Li, Kechun Li, Keshen Li, Yuxin Li, Shaoliang Li, Shu-Xin Li, Hong-Zheng Li, Tianye Li, Qun Li, Zhen Li, Mengling Li, Jia-Da Li, Baoqing Li, Pu Li, Xingli Li, Bingkun Li, Nien-Chi Li, Tiewei Li, Daniel Tian Li, Rong-Bing Li, Wei-Yang Li, Rong Li, Mingkun Li, Binxing Li, Zixiao Li, Guixin Li, Quanzhang Li, Da-wei Li, Xiumei Li, Melody M H Li, Peibo Li, Huanjun Li, Chung-Hao Li, Liuzheng Li, Zhanjun Li, Yifei Li, Tianming Li, Chang-Sheng Li, Tianyou Li, Jipeng Li, Longxuan Li, Shi-Guang Li, Wenxiu Li, Zhuang Li, Yu-Hao Li, Shilin Li, Shili Li, Meiqing Li, Hengyu Li, Yinhao Li, Junying Li, Mufan Li, Chun-Lai Li, Shiya Li, Xiao-Jiao Li, Li Li, Hanxue Li, Lulu Li, L P Li, Xiaoqin Li, Chunmei Li, Mingjun Li, Yuanhua Li, Qiaolian Li, Ji-Cheng Li, Haolong Li, Xuanzheng Li, Peng-li Li, Quan Li, Xue-Ying Li, Yongzhe Li, Tianyi Li, Qingfeng Li, Nanlong Li, Ping Li, Fangzhou Li, Nien-Chen Li, Yuanchuang Li, Haiying Li, Yunting Li, Hong-Yan Li, Shengbiao Li, Yue-Rui Li, Ruidong Li, Y M Li, Sijie Li, Meilan Li, D C Li, Andrew C Li, Jianye Li, Qiuyan Li, Tingguang Li, Xiangyang Li, Chunjie Li, Tianfeng Li, Anna Fen-Yau Li, Minghui Li, Jiangfeng Li, Jie-Pin Li, Kaiyi Li, Junyi Li, Dongtao Li, Fengyuan Li, Chenxi Li, Zuo-Lin Li, Zhengwei Li, Yan-Chun Li, Suiyan Li, Qiaoqiao Li, Xiaotian Li, Zhenguang Li, Jia-Ru Li, Pei-Qin Li, Chun-Xiao Li, Shu-Hong Li, Shuyue Li, Quan-Zhong Li, Tongzheng Li, Fangyan Li, Duo Li, Ren Li, Hongye Li, Lanfang Li, Mingwei Li, Wenxin Li, W J Li, Zhijia Li, Jingtong Li, Lucy Li, Zhengpeng Li, Xiayu Li, Baolin Li, Cuilan Li, Yuting Li, Xiaobo Li, Meijia Li, Shujiao Li, Kun-Ping Li, Weirong Li, Weihua Li, Runzhao Li, Xiang-Dong Li, Yanxin Li, Xiufeng Li, Yingjun Li, Xiaohuan Li, Ying-Qin Li, Fan Li, Jun Z Li, Yiheng Li, Taiwen Li, Xiaorong Li, Haifeng Li, Liping Li, Rena Li, Jiangtao Li, Yu-Jui Li, Rui-Jún Eveline Li, Xuanxuan Li, Bing-Mei Li, Yunman Li, Shuhua Li, Chunying Li, Leipeng Li, Weiheng Li, Baizhou Li, Han-Ru Li, Sheng Li, Yaqiang Li, Guoyin Li, Qiwei Li, Chengjun Li, Jianxiong Li, Ji Li, Huaying Li, Tuojian Li, Yixin Li, Ziyue Li, Juntong Li, Xiang Li, Chaonan Li, Yu-Chia Li, Heying Li, Shaomin Li, Yuxuan Li, Xuan-Ling Li, Bingshan Li, Jiahao Li, Shibao Li, Ruijin Li, Kunlong Li, Xiaofeng Li, Zhaolun Li, Litao Li, Ruyi Li, Wanxin Li, Jinsong Li, Ying-Lan Li, Yulin Li, Shaojian Li, Mohan Li, Yan-Xue Li, Enhong Li, Xiangnan Li, Yong-Jun Li, Hang Li, Ziming Li, Jing-Ming Li, Yuanchang Li, Xiao-Lin Li, Yicun Li, Zhao-Yang Li, K-L Li, Xinjia Li, Bin Li, Jianhai Li, Peiwu Li, Youran Li, Changyu Li, Ming Zhou Li, Z Li, Xinmei Li, Wulan Li, Haoxian Li, Xiaozhao Li, Da-Lei Li, Jinming Li, Huihui Li, Kailong Li, Qiankun Li, Shengxu Li, Xiuli Li, Yulong Li, Ru-Hao Li, Zhi-Peng Li, Lanzhou Li, Tingsong Li, Binjun Li, Chen Li, Yawei Li, Chao Bo Li, Donghua Li, Siming Li, Fengli Li, Song Li, Hsin-Hua Li, You Li, Dongfeng Li, Zhen-Yuan Li, Xuelin Li, Xueyang Li, Bao Li, Yin Li, Cai-Hong Li, Dejun Li, Yufeng Li, Miaoxin Li, Hu Li, Bei Li, W H Li, Sha Li, Ya-Qiang Li, Xiushen Li, Jinlin Li, Xiaoqing Li, Shuaicheng Li, Xuebiao Li, Yingyi Li, Maolin Li, Jiyang Li, Zhongxuan Li, Linting Li, Zhong-Xin Li, Enhao Li, Shengliang Li, Hujie Li, Yue-Ming Li, Zhaohan Li, Alexander Li, Wen-juan Li, Pilong Li, Yun-Peng Li, C X Li, Huanan Li, Miao X Li, KeZhong Li, Linying Li, Chu-Qiao Li, Fa-Hong Li, Changzheng Li, Yaokun Li, Zhi-Gang Li, Yufan Li, Liangqian Li, Guanghui Li, Xiongfeng Li, Side Li, Timmy Li, Jiezhen Li, Qiuya Li, Haitao Li, Yufen Li, Qin Li, Annie Li, Wenge Li, Xueren Li, Chun-Mei Li, Meng-Yao Li, Chung-I Li, Zhi-Bin Li, Junping Li, Xiao Li, PeiQi Li, Xiaobing Li, Liangdong Li, Yan Li, Shengchao A Li, Pan Li, Huiqiong Li, Guigang Li, Lucia M Li, Chunzhu Li, Chengquan Li, Zexu Li, Zhilei Li, Tiantian Li, Wenyong Li, Desen Li, Tianjun Li, Zihao Li, Fadi Li, Huawei Li, Yu-quan Li, Jihua Li, Jingping Li, Zhiquan Li, Zeyu Li, Zongdi Li, Ming V Li, Aowen Li, L K Li, Aimin Li, Tiehua Li, Guohong Li, Botao Li, L-Y Li, Xiuqi Li, Zhenhua Li, Zhengda Li, Haotong Li, Luhan Li, Yuancong Li, Tian Li, Yuxiu Li, Beibei Li, Changhong Li, Yvonne Li, Zhichao Li, Jiayuan Li, Yige Li, Siguang Li, Chengqian Li, Weiye Li, Dong-fei Li, Xiangchun Li, Hailong Li, Kun-Peng Li, Haijun Li, Si Li, Ji-Feng Li, Wanqian Li, Zijing Li, Wentao Li, Yuchuan Li, Xuhong Li, Hongyun Li, Zhonggen Li, Xiong Li, Penghui Li, Huiting Li, Xiaolong Li, Linqing Li, Jiawei Li, Defa Li, X L Li, Yuyan Li, Kawah Li, Shupeng Li, Zhenfei Li, Zhuo Li, Han-Wei Li, Weina Li, Xiao-Hui Li, Rui-Fang Li, Jianzhong Li, Bing Li, Huihuang Li, Yunmin Li, Yanying Li, Gui Lin Li, Chenrui Li, Dengfeng Li, N Li, Xiaotong Li, Chensheng Li, Ming-Qing Li, Yongxue Li, Bao-Shan Li, Zhimei Li, Jiao Li, Jingming Li, Jinxia Li, De-Tao Li, Shu Li, Julia Li, Huilan Li, Xin-Ya Li, Chunsheng Li, Chengjian Li, Ying-na Li, Guihua Li, Zhiyuan Li, Supeng Li, Yiju Li, Yuanhe Li, Guangxiao Li, Xueqin Li, Peixin Li, Feng-Feng Li, Zu-Ling Li, Yunjiu Li, Dayong Li, Zonghong Li, Lingjiang Li, Yuhan Li, Fuyuan Li, H-F Li, Chunxia Li, Zhen-Li Li, Zhengying Li, Zhaoshui Li, Yali Li, Yu-Hui Li, Chuang Li, Jiajun Li, Can Li, Zhe Li, Stephen Li, Shuangding Li, Mangmang Li, Kaiyuan Li, Xiaopeng Li, Anan Li, Luying Li, Jiajv Li, Xiaoquan Li, Yanxi Li, Yongjing Li, Huayao Li, Jiqing Li, Huixue Li, Boxuan Li, Yongqi Li, Qingyuan Li, Fengqi Li, Yuqing Li, Zhigang Li, Guiyang Li, Guo-Qiang Li, Yanbo Li, Sanqiang Li, Hongyu Li, Guangping Li, Jinxin Li, Xinrong Li, Yayu Li, Huaixing Li, Minyue Li, Hong-Mei Li, Jutang Li, Mengxia Li, Yongxiang Li, Qilong Li, Songlin Li, Dijie Li, Yizhe Li, Yan Bing Li, Jiani Li, Lianjian Li, Yiliang Li, Xinpeng Li, Hongxing Li, Wanyi Li, Mi Li, Guo Li, Jingxia Li, Xiu-Ling Li, Fuhai Li, Ruijia Li, Yumiao Li, Jiexi Li, Kecheng Li, Junxu Li, Junya Li, Jiang Li, Shengxian Li, Qingyang Li, Yuxi Li, Chenxuan Li, Xiao-Dong Li, Xinghuan Li, Zhenlu Li, Xiaolei Li, Huilong Li, Xiao-Gang Li, Zhenhui Li, Chunjun Li, Shu-Fen Li, Yinghua Li, Yanjie Li, Chaoying Li, Juanjuan Li, Qiu Li, Kunlun Li, Shiquan Li, Xiangdong Li, Zhenjia Li, Jifang Li, Zhizhong Li, Ding Yang Li, Chenlong Li, Shujin Li, Weining Li, Wu-Jun Li, Yumao Li, Bin-Kui Li, Honglian Li, Ya-Zhou Li, Hongyi Li, Fu-Rong Li, Honghua Li, Lanjuan Li, Man-Zhi Li, Xiancheng Li, Yanmei Li, Zhihua Li, Minqi Li, Saijuan Li, Danxi Li, Mimi Li, Yingjie Li, Yuan-Hai Li, Lujie Li, Minghao Li, Meifen Li, Yifeng Li, Huanqing Li, Yuhang Li, Jianhua Li, Chanjuan Li, Lingyi Li, Yanchuan Li, Bai-Qiang Li, Chunmiao Li, Jiong-Ming Li, Yongqiang Li, Linsheng Li, Mingyao Li, Ze Li, R H L Li, Guisen Li, Dongyang Li, Jinglin Li, Honglong Li, Mingfang Li, Hanmei Li, Chenmeng Li, Shiyang Li, Jianing Li, Xinsheng Li, Jin-Jiang Li, Zhi-Xing Li, Chang Li, Jiwei Li, Weifeng Li, Wenhui Li, Sichen Li, Qingsheng Li, Liangji Li, Lixiang Li, Jin-Liang Li, Xiaoqiong Li, You Ran Li, Yixiao Li, Kathy H Li, Yuhua Li, Deqiang Li, Y Li, Mingyue Li, Zipeng Li, Caixia Li, Hongli Li, Yanfeng Li, Yaqin Li, Yu-He Li, Shasha Li, S-C Li, Xi Li, Siyi Li, Minmin Li, Manna Li, Dawei Li, Xun Li, Ming-Jiang Li, Sitao Li, Tinghua Li, Zhenfen Li, Shuo Li, Si-Ying Li, Xinyi Li, Jenny J Li, Xue-zhi Li, Xiaonan Li, Zhenyu Li, Ting Li, Xiang-Yu Li, Duan Li, Lei Li, Hongde Li, Fengqing Li, Yanchang Li, Xunjia Li, Ruixia Li, Nanzhen Li, Hongxue Li, Bingjie Li, Xiaojing Li, Xinlin Li, Yu-Ying Li, Wenli Li, Mengze Li, Kaiwei Li, Huangyuan Li, Lili Li, Junxin Li, Wei-Jun Li, Guoyan Li, Fei-Lin Li, Nuomin Li, Yanyan Li, Shulin Li, Shanglai Li, Taibo Li, Yue Li, Junqin Li, JunBo Li, Jun-Ru Li, Xueying Li, Zhongcai Li, Zhaobing Li, Linxin Li, Jen-Ming Li, Chen-Chen Li, Hongquan Li, Chuan F Li, Yanxiang Li, Yi-Wen Li, Shihong Li, Rulin Li, Huifeng Li, Lijuan Li, Yuanhong Li, Shengbin Li, Jingyu Li, Xuewei Li, Long Li, Min-Dian Li, Wenjia Li, Xiatian Li, Yangxue Li, Chengnan Li, Chuanyin Li, Yiqiang Li, Zhenzhou Li, Xiawei Li, Binglan Li, Yutong Li, Yingnan Li, Ge Li, Xinzhong Li, Chenyao Li, Jun-Yan Li, Boru Li, Ruixue Li, Zemin Li, Jixi Li, Chris Li, Jicheng Li, Chuanning Li, Jiafei Li, Yingying Li, Gaizhi Li, Chien-Hsiu Li, Xiangcheng Li, Siqi Li, Chunxing Li, Qiao-Xin Li, Huang Li, Shu-Fang Li, Qiusheng Li, Weiqin Li, Xinming Li, Yongjun Li, Mengyang Li, Guo-Jian Li, Chenglong Li, Nan Li, Yipeng Li, Mingxing Li, Xin-Yu Li, Chunyu Li, Jinwei Li, Xuhua Li, Yu-Xiang Li, Long Shan Li, Yanze Li, Xiao-Feng Li, W Li, Fengjuan Li, Hainan Li, Yutian Li, Xiliang Li, Shuangmei Li, Ying-Bo Li, Duanbin Li, Maogui Li, Dan Li, Sumei Li, Peilong Li, Kang Li, Yinghao Li, Lirong Li, Wenhong Li, Audrey Li, Yijian Li, Guang Y Li, Xianyong Li, Shilan Li, Guang-Li Li, Bang-Yan Li, Enxiao Li, Jianrui Li, Guohua Li, Kezhen Li, Xingxing Li, Ellen Li, Yijie Li, Suwei Li, Shuyu D Li, Ruiwen Li, Jiandong Li, Fangyong Li, Binru Li, Yuchao Li, Hanlu Li, Jianang Li, Xue-Peng Li, Sheng-Tien Li, Shihao Li, Yazhou Li, Jun-Ling Li, Caesar Z Li, Lang Li, Feifei Li, Kejuan Li, Qinghong Li, Qiqiong Li, Xinxiu Li, Chongyi Li, Yi-Ying Li, Shaodan Li, Yongzheng Li, Da-Hong Li, Xiao-mei Li, Jiejie Li, Ruihuan Li, Yaoyao Li, Yueguo Li, Mo Li, Ming-Hao Li, Hongsen Li, Menghua Li, Ka Li, Kaixin Li, Fuping Li, Jianbo Li, Xing-Wang Li, Chong Li, Fugen Li, Yuwei Li, Xiaochen Li, Zizhuo Li, Xiaoxiao Li, Le-Ying Li, Pengcui Li, Bing-Heng Li, Xiaoman Li, Xiaohong Li, Yuan Hao Li, Jianchun Li, Wenxiang Li, Zhaoliang Li, Guo-Ping Li, Zhifei Li, Jinhui Li, Yuanyou Li, Chongyang Li, Wanyan Li, Yumin Li, Longyu Li, X B Li, Jianguo Li, En Li, Ximei Li, Shaoyong Li, Kai-Wen Li, Guandu Li, Yixue Li, Junfeng Li, Xin-Chang Li, Yue-Ying Li, Kongdong Li, Lian Li, Xinmiao Li, Chenyang Li, Jiacheng Li, Xiaohua Li, Zhuangzhuang Li, Xiaohui Li, Cang Li, Xuepeng Li, Mingjiang Li, Zongyu Li, Shujie Li, Yanbin Li, Shiliang Li, Qinrui Li, Yiming Li, Xiao-Tong Li, Tie Li, Wei-Bo Li, Xiaoyi Li, Liyan Li, Xinke Li, Xiaokun Li, Ming-Wei Li, Minzhe Li, Wenfeng Li, Karen Li, X Li, Meifang Li, Yanjing Li, Maosheng Li, Ju-Rong Li, Shibo Li, Jin Li, Li-Na Li, Hui Li, Fangqi Li, Xiaoguang Li, Xian Li, Danjie Li, Vivian S W Li, Ranchang Li, Defu Li, Amy Li, Haoyu Li, Xiaoyao Li, M-J Li, Jiao-Jiao Li, Zhu Li, Rongling Li, Tong-Ruei Li, Ben Li, Yingxia Li, Yonghe Li, Xinwei Li, Yu-I Li, Shunhua Li, Mingxi Li, Qionghua Li, Guo-Li Li, Xingchen Li, Tianjiao Li, Gui-Rong Li, Yunpeng Li, Qiong Li, Songyu Li, Shi-Fang Li, Shude Li, Zhibin Li, Yaxiong Li, Qing-Fang Li, Shengwen Li, Gui-Bo Li, Xueer Li, Zihai Li, Yue-Jia Li, Haihong Li, Peifen Li, Mingzhou Li, Taixu Li, Jiejing Li, Meng-Miao Li, Meiying Li, Chunlian Li, Meng Li, Cun Li, T Li, Yinghui Li, Feilong Li, Sin-Lun Li, Weiling Li, Mengfan Li, Jie Li, Shiyan Li, Lianbing Li, Yanchun Li, Xuze Li, Jialin Li, Wenjian Li, He Li, Bichun Li, Hanqin Li, Guoge Li, Wen-Wen Li, Keying Li, Minze Li, Xingcheng Li, Wanshun Li, Congxin Li, Xiangrui Li, Caolong Li, Michelle Li, Chaojie Li, J Li, Zhi-Jian Li, Jianwei Li, Jiexin Li, Hongyan Li, Zhen-Xi Li, Guangdi Li, Xiaxia Li, Nien Li, Yuefeng Li, Peiyuan Li, Tiansen Li, Chi-Yuan Li, Xiangfei Li, Xue Li, Fen Li, Jieshou Li, Roger Li, Mengqing Li, Menglu Li, Huiqing Li, Yantao Li, Ruolin Li, Yongle Li, Haying Li, Shao-Dan Li, Muzi Li, Gen Li, Dong-Ling Li, Chenwen Li, Le Li, Yong-Jian Li, Si-Wei Li, Manru Li, Yingxi Li, Caili Li, Yuqian Li, Wei-Dong Li, Guannan Li, Ya-Feng Li, Wenlong Li, Yuna Li, Shengli Li, Shugang Li, Xuan Li, Yongze Li, Yongxin Li, Lu Li, Zhuo-Rong Li, Qinglin Li, Bingbing Li, Runzhi Li, Qi-Jing Li, Zhenyan Li, Ji Xia Li, Yu-Ye Li, Meizi Li, Yuezheng Li, Zhengnan Li, Jianglong Li, Xiaozheng Li, Huili Li, Hongzhe K Li, Xiao-Qiu Li, Jiejia Li, Yi-Yang Li, Zhihui Li, Fujun Li, Ni Li, Luxuan Li, Qiang-Ming Li, Yakui Li, Huafu Li, Xinye Li, Chunliang Li, Ruiyang Li, Chun Li, Jianan Li, Wenfang Li, Xiangling Li, Sung-Chou Li, Lianhong Li, Cheng Li, Tiegang Li, Zhong Li, Shuang-Ling Li, Xiao-Long Li, Xiaofei Li, Hung-Yuan Li, Zhang Li, Jianxin Li, H Li, Dongliang Li, Chenxiao Li, Hongjia Li, Xiao-Jing Li, Y H Li, Jian Li, Daoyuan Li, Baichuan Li, Zhenzhe Li, Jian-Mei Li, Kaimi Li, Peiran Li, Qiao Li, Yi-Yun Li, Xiao-Cheng Li, Yike Li, Yihan Li, Junsheng Li, Jiayu Li, Wen-Ya Li, Rongxia Li, Yunlun Li, Guoqin Li, Huiqin Li, Chunlin Li, Jisen Li, Peng Peng Li, Kenli Li, Guanglu Li, Xiushi Li, Dongmin Li, Jian-Jun Li, Fengyi Li, Yanling Li, Juanni Li, C Li, You-Mei Li, Beixu Li, Guiyuan Li, Suk-Yee Li, Shengjie Li, Yuanyuan Li, Xiaona Li, Shanyi Li, Chih-Chi Li, Hongbo Li, Xinhui Li, Jun Li, Mingzhe Li, Hongjuan Li, Senmao Li, Mingjie Li, Ling-Jie Li, Hong-Chun Li, Yaying Li, Liqun Li, Changxian Li, Chunqing Li, Yanni Li, Yongsheng Li, Xiujuan Li, Huifang Li, Lingling Li, Xinhua Li, Minerva X Li, Alexander H Li, Wendeng Li, Ding Li, Ming-Yang Li, Shengze Li, Linyan Li, Hewei Li, Da-Jin Li, Xiao-kun Li, Yuanhao Li, Ji-Lin Li, Congcong Li, Juan Li, Xiaobin Li, Shaoqi Li, Yuehua Li, Jinfeng Li, Shiheng Li, Hsiao-Fen Li, Mengjiao Li, Tianxiang Li, Meng-Meng Li, Liangkui Li, Tian-chang Li, Yahui Li, Wenlei Li, Xi-Xi Li, Haiyan Li, Xujun Li, Chi-Ming Li, Yi-Ning Li, Dandan Li, Yunan Li, Sherly X Li, Jiazhou Li, Zhijun Li, Zechuan Li, Wanling Li, Zhiwei Li, Xueshan Li, Jiangbo Li, Xiaohan Li, Huijie Li, Zhongwen Li, W W Li, Yalan Li, Xuejun Li, Shunwang Li, Yaqing Li, Chao Li, Yaqiao Li, Bingsheng Li, Jianfang Li, Shubo Li, Qi-Fu Li, Zi-Zhan Li, Haoran Li, Xiaoliang Li, Xinyuan Li, Maoquan Li, Chumei Li, Shijie Li, Zhanquan Li, Wenguo Li, Fangyuan Li, Xiaochun Li, Rui Li, Xuemin Li, Shanpeng Li, Wei-Na Li, Dong-Run Li, Yunxi Li, Xuyi Li, Yunchu Li, Zhengyao Li, Jinghao Li, Y-Y Li, Xiaofang Li, Tuoping Li, Pengyun Li, Lin-Feng Li, Ziqing Li, Shuangxiu Li, Yongjin Li, Chenhao Li, Weizu Li, Deming Li, Jiuyi Li, Chun-Xu Li, Luyao Li, Desheng Li, Long-Yan Li, Fuyu Li, Lingzhi Li, Xiao-Sa Li, Kunlin Li, Shu-Qi Li, Zehua Li, Mengyuan Li, Congye Li, Wensheng Li, Dehai Li, Qingshang Li, Jiannan Li, Guanbin Li, Zhiyi Li, Xing Li, Zhaoyong Li, SuYun Li, Shiyi Li, Suchun Li, Yanan Li, Jiayan Li, YueQiang Li, Xiangping Li, H-H Li, Jinman Li, Dongdong Li, Hao Li, Liliang Li, Mengxi Li, Keyuan Li, Shaojing Li, S S Li, Tong Li, Yilong Li, Lihua Li, Xue-Lian Li, Yansen Li, Hai Li, Zhi-Yuan Li, Jingfeng Li, Yanli Li, Yuan-Jing Li, Kaibin Li, Xiaohu Li, Wenjie Li, Ruikai Li, Qiyong Li, Ruixi Li, Zhonglian Li, Dalin Li, Kun Li, Qizhai Li, Pengju Li, Peifeng Li, Ai-Jun Li, Yueting Li, YaJie Li, Zijian Li, Yanqing Li, Jixuan Li, Zhandong Li, Xuejie Li, Gaizhen Li, Liang Li, Huafang Li, Nianyu Li, Chenlu Li, X-L Li, Shawn S C Li, Cuiguang Li, Dongye Li, F Li, Chunhong Li, Yuan Li, Kunpeng Li, Zhenghao Li, Chun-Bo Li, Zhantao Li, Xinle Li, Wuguo Li, Bing-Hui Li, Honggang Li, Jingyong Li, Shikang Li, Shi-Ying Li, Ming Xing Li, Ming-Xing Li, Marilyn Li, Bei-Bei Li, Hong-Lian Li, Shishi Li, Haitong Li, Yuli Li, Ruibing Li, Qingfang Li, Qibing Li, Wende Li, Heng Li, Xiao-Na Li, Xidan Li, Yixing Li, Chengcheng Li, Yu-Jin Li, Baoting Li, Ka Wan Li, Huiyou Li, Binbin Li, Xinyao Li, Gui-xing Li, Niu Li, Shunle Li, Siyue Li, Diyan Li, Mengyao Li, Yixuan Li, Shan-Shan Li, Zhuanjian Li, Gerard Li, Yuyun Li, Zhiqiong Li, Zonglin Li, Pik Yi Li, Jingxin Li, Defeng Li, Zu-guo Li, Xin-Zhu Li, Jia-Xin Li, Kuiliang Li, Pindong Li, Hualian Li, Junhong Li, Youchen Li, W Y Li, Yi-Heng Li, Runbing Li, Yanmin Li, Jingyi Li, Yuxiang Li, Hao-Fei Li, Yining Li, Xiurong Li, Haiyu Li, Huijuan Li, Yunze Li, Xu-Zhao Li, Yanzhong Li, Kainan Li, Guohui Li, Xiaoyan Li, Xu-Bo Li, Yue-Chun Li, Jiahui Li, Huiping Li, Kangyuan Li, Biao Li, Xiaoxuan Li, Anyao Li, Qing-Chang Li, Hongliang Li, Dalei Li, Zongjun Li, Changqing Li, Hanting Li, Dong-Jie Li, Xiaomin Li, Dengxiong Li, Yi-Shuan J Li, Tinghao Li, Zhouxiang Li, Yun-tian Li, Jianliang Li, Guangzhao Li, Yixi Li, Shuyu Dan Li, S A Li, Jinjie Li, Liming Li, Wenqun Li, Guixia Li, Yinan Li, Aoxi Li, Yuanjing Li, Linqi Li, Xixi Li, Bingjue Li, Binghu Li, Yu-Hang Li, Shuhui Li, Mengying Li, Yihong Li, Yaxian Li, Dali Li, Zhiming Li, Xuemei Li, Xueting Li, Yongting Li, Hongxia Li, Zhenjun Li, Danyang Li, Tiandong Li, Di-Jie Li, Bo Li, Jinliang Li, Qiji Li, Zhipeng Li, Xiaoping Li, Linhong Li, Taoyingnan Li, Lieyou Li, Huabin Li, Mao Li, Yongchao Li, Xiaoting Li, Ruotai Li, Yaojia Li, Xiao-Yao Li, Shangming Li, Yaqi Li, Yibo Li, Gui-Hua Li, Zhihong Li, Yandong Li, Chaowei Li, Huiyuan Li, Yuchun Li, Boya Li, Lamei Li, O Li, Joyce Li, Suheng Li, Hui-Ping Li, Junru Li, Zhiqiang Li, Jiangchao Li, Hecheng Li, Yueping Li, Changkai Li, Zhenglong Li, Yajuan Li, Chaoqian Li, Yu-Cheng Li, Yirun Li, Haomiao Li, Qianqian Li, YiQing Li, Zhengliang Li, Weijie Li, Wei-Qin Li, Zongyi Li, Qingxian Li, Dan-Dan Li, Yeshan Li, Zirui Li, Keke Li, Yongpeng Li, Chanyuan Li, Jianbin Li, Shiying Li, Zhongzhe Li, Yumei Li, Xiang-Ping Li, Wenqiang Li, Pei-Shan Li, Zaibo Li, Guangming Li, Xiaoqiang Li, Hanxiao Li, Jiansheng Li, Shuying Li, Xiaomei Li, Pengjie Li, Jiajia Li, Jingwen Li
articles
Wan-Hong Li, Li Zhang, Yue-Ying Li +6 more · 2022 · International journal of molecular sciences · MDPI · added 2026-04-24
Alcohol abuse can lead to alcoholic hepatitis (AH), a worldwide public health issue with high morbidity and mortality. Here, we identified apolipoprotein A-IV (APOA4) as a biomarker and potential ther Show more
Alcohol abuse can lead to alcoholic hepatitis (AH), a worldwide public health issue with high morbidity and mortality. Here, we identified apolipoprotein A-IV (APOA4) as a biomarker and potential therapeutic target for AH. APOA4 expression was detected by Gene Expression Omnibus (GEO) databases, Immunohistochemistry, and qRT-PCR in AH. Bioinformatics Methods (protein-protein interaction (PPI) network, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and Gene Set Enrichment Analysis (GSEA) were used to show down-stream gene and pathways of APOA4 in AH. AML-12 cells were used to evaluate the biological function of APOA4 using an ELISA kit (AST, ALT, and IL-1β) and flow cytometry (ROS activity). Both in vivo and in vitro, APOA4 expression was significantly elevated in the AH model induced by alcohol (ETOH). AML-12 cell damage was specifically repaired by APOA4 deficiency, while AST, ALT, and IL-1β activity that was increased by ETOH (200 µmol, 12 h) were suppressed. APOA4 inhibition increased intracellular ROS induced by ETOH, which was detected by flow cytometry. Functional and PPI network analyses showed Fcgamma receptor (FCGR) and platelet activation signaling were potential downstream pathways. We identified Show less
📄 PDF DOI: 10.3390/ijms24010670
APOA4
P Li, X Zeng, Y Liu +1 more · 2022 · Bulletin of experimental biology and medicine · Springer · added 2026-04-24
P Li, X Zeng, Y Liu, M Lin Show less
This study aims to understand the molecular basis of manganese superoxide dismutase (MnSOD) impacts on breast cancer cell growth. Modulation of the level of MnSOD by genetic engineering led significan Show more
This study aims to understand the molecular basis of manganese superoxide dismutase (MnSOD) impacts on breast cancer cell growth. Modulation of the level of MnSOD by genetic engineering led significant changes in the expression of angiopoietin-like protein 4 (ANGPTL4) and activity of peroxisome proliferator-activated receptor α (PPARα) in MCF7 cells. PPARα agonist increased ANGPTL4 expression inhibited by MnSOD. Proliferation of MCF7 cells was inhibited by MnSOD, however, ANGPTL4 transduction into MCF7 cells with MnSOD overexpression significantly stimulated cell proliferation. MnSOD induced G0/G1 cell cycle arrest, nevertheless, ANGPTL4 transduction significantly reduced the percentage of cells in G0/G1 phase overexpressing MnSOD. In conclusion, MnSOD suppressed the expression of ANGPTL4 in breast cancer cells via the PPARα signaling pathway, and ANGPTL4 was involved in MnSOD-mediated proliferation inhibition and cell cycle arrest. Show less
📄 PDF DOI: 10.1007/s10517-022-05526-y
ANGPTL4
Qian Guo, Qinfeng Cai, Fang Huang +7 more · 2022 · Journal of Alzheimer's disease : JAD · added 2026-04-24
As an acetylcholinesterase inhibitor (AChEI), Huperzine-A (Hup-A) is marketed for treatment of mild to moderate Alzheimer's disease (AD) for decades in China. However, Hup-A causes some side effects. Show more
As an acetylcholinesterase inhibitor (AChEI), Huperzine-A (Hup-A) is marketed for treatment of mild to moderate Alzheimer's disease (AD) for decades in China. However, Hup-A causes some side effects. To search for new analogs or derivatives of Hup-A, we produced five Lycopodium alkaloids and two analogues by chemical synthesis: Lyconadins A-E, H-R-NOB, and 2JY-OBZ4. To systematically evaluate the therapeutic effects of the seven compounds on AD cell models. We assessed the effects of the seven compounds on cell viability via CCK-8 kit and used HEK293-hTau cells and N2a-hAPP cells as AD cell models to evaluate their potential therapeutic effects. We examined their effects on cholinesterase activity by employing the mice primary neuron. All compounds did not affect cell viability; in addition, Lyconadin A and 2JY-OBZ4 particularly increased cell viability. Lyconadin D and Lyconadin E restored tau phosphorylation at Thr231, and H-R-NOB and 2JY-OBZ4 restored tau phosphorylation at Thr231 and Ser396 in GSK-3β-transfected HEK293-hTau cells. 2JY-OBZ4 decreased the level of PP2Ac-pY307 and increased the level of PP2Ac-mL309, supporting that 2JY-OBZ4 may activate PP2A. Lyconadin B, Lyconadin D, Lyconadin E, H-R-NOB, and 2JY-OBZ4 increased sAβPPα level in N2a-hAPP cells. 2JY-OBZ4 decreased the levels of BACE1 and sAβPPβ, thereby reduced Aβ production. Seven compounds exhibited weaker AChE activity inhibition efficiency than Hup-A. Among them, 2JY-OBZ4 showed the strongest AChE inhibition activity with an inhibition rate of 17% at 10μM. Among the seven Lycopodium compounds, 2JY-OBZ4 showed the most expected effects on promoting cell viability, downregulating tau hyperphosphorylation, and Aβ production and inhibiting AChE in AD. Show less
no PDF DOI: 10.3233/JAD-220704
BACE1
Haonan Zeng, Zhanming Zhong, Zhiting Xu +7 more · 2022 · BMC genomics · BioMed Central · added 2026-04-24
Average backfat thickness (BFT) is a critical complex trait in pig and an important indicator for fat deposition and lean rate. Usually, genome-wide association study (GWAS) was used to discover quant Show more
Average backfat thickness (BFT) is a critical complex trait in pig and an important indicator for fat deposition and lean rate. Usually, genome-wide association study (GWAS) was used to discover quantitative trait loci (QTLs) of BFT in a single population. However, the power of GWAS is limited by sample size in a single population. Alternatively, meta-analysis of GWAS (metaGWAS) is an attractive method to increase the statistical power by integrating data from multiple breeds and populations. The aim of this study is to identify shared genetic characterization of BFT across breeds in pigs via metaGWAS.  RESULTS: In this study, we performed metaGWAS on BFT using 15,353 pigs (5,143 Duroc, 7,275 Yorkshire, and 2,935 Landrace) from 19 populations. We detected 40 genome-wide significant SNPs (Bonferroni corrected P < 0.05) and defined five breed-shared QTLs in across-breed metaGWAS. Markers within the five QTL regions explained 7 ~ 9% additive genetic variance and showed strong heritability enrichment. Furthermore, by integrating information from multiple bioinformatics databases, we annotated 46 candidate genes located in the five QTLs. Among them, three important (MC4R, PPARD, and SLC27A1) and seven suggestive candidate genes (PHLPP1, NUDT3, ILRUN, RELCH, KCNQ5, ITPR3, and U3) were identified. QTLs and candidate genes underlying BFT across breeds were identified via metaGWAS from multiple populations. Our findings contribute to the understanding of the genetic architecture of BFT and the regulating mechanism underlying fat deposition in pigs. Show less
📄 PDF DOI: 10.1186/s12864-022-09036-z
MC4R
Yiying Tao, Youwen Lin, Ling An +5 more · 2022 · Allergologia et immunopathologia · added 2026-04-24
Diabetes is a serious disease that could greatly increase the risk of cardiovascular complications, whereas the underlying pathology of DN is still unknown. GPRC5B is a member of the RAIG subfamily of Show more
Diabetes is a serious disease that could greatly increase the risk of cardiovascular complications, whereas the underlying pathology of DN is still unknown. GPRC5B is a member of the RAIG subfamily of type 3 (family C) GPCR, and its role in DN is still unclear. To unveil the role of GPRC5B in diabetic nephropathy (DN) progression and investigate the potential signaling pathway. Podocytes were stimulated with high glucose and expression of GPRC5B was analyzed by qPCR and western blot. Then the level of GPRC5B was depleted by siRNA transfection and inflammatory cytokine level was monitored by ELISA assay. The ECM depostion and the activation of NF-κB pathway were detected by Immunoblot. We investigated the possible role of GPRC5B in the pathology of diabetic nephropathy. We found GPRC5B was highly expressed in high glocuse (HG) induced podocytes. The depletion of GPRC5B inhibited HG induced cell inflammation. In addition, the ablation of GPRC5B suppressed the HG induced ECM deposition. We further found GPRC5B could alleviate the inflammation and extracellular matrix deposition of HG-induced podocytes through NF-κB pathway. We therefore thought GPRC5B could serve as a promising target for the treatment of diabetic nephropathy. G-protein-coupled receptors. Show less
no PDF DOI: 10.15586/aei.v50i2.566
GPRC5B
Weining Li, Zhaojun Wang, Shenghao Luo +3 more · 2022 · Animals : an open access journal from MDPI · MDPI · added 2026-04-24
Feed efficiency (FE) traits are key factors that can influence the economic benefits of pig production. However, little is known about the genetic architecture of FE and FE-related traits. This study Show more
Feed efficiency (FE) traits are key factors that can influence the economic benefits of pig production. However, little is known about the genetic architecture of FE and FE-related traits. This study aimed to identify SNPs and candidate genes associated with FE and FE-related traits, namely, average daily feed intake (ADFI), average daily gain (ADG), the feed conversion ratio (FCR), and residual feed intake (RFI). The phenotypes of 5823 boars with genotyped data (50 K BeadChip) from 1365 boars from a nucleus farm were used to perform a genome-wide association study (GWAS) of two breeds, Duroc and Yorkshire. Moreover, we performed a genetic parameter estimation for four FE and FE-related traits. The heritabilities of the FE and FE-related traits ranged from 0.13 to 0.36, and there were significant genetic correlations (-0.69 to 0.52) of the FE and FE-related traits with two growth traits (age at 100 kg and backfat thickness at 100 kg). A total of 61 significant SNPs located on eight different chromosomes associated with the four FE and FE-related traits were identified. We further identified four regions associated with FE and FE-related traits that have not been previously reported, and they may be potential novel QTLs for FE. Considering their biological functions, we finally identified 35 candidate genes relevant for FE and FE-related traits, such as the widely reported Show less
📄 PDF DOI: 10.3390/ani12151902
MC4R
Jinjin Zhang, Haixia Wang, Hongbin Chen +6 more · 2022 · Autophagy · Taylor & Francis · added 2026-04-24
Idiopathic pulmonary fibrosis (IPF) is characterized by lung scarring and has no effective treatment. Fibroblast-to-myofibroblast differentiation and myofibroblast proliferation and migration are majo Show more
Idiopathic pulmonary fibrosis (IPF) is characterized by lung scarring and has no effective treatment. Fibroblast-to-myofibroblast differentiation and myofibroblast proliferation and migration are major clinical manifestations of this disease; hence, blocking these processes is a practical treatment strategy. Here, highly upregulated Show less
📄 PDF DOI: 10.1080/15548627.2022.2046448
CLN3
Kuan Hu, Lei Yao, Lei Zhou +1 more · 2022 · International journal of general medicine · added 2026-04-24
The Chromobox (CBX) family members were involved in a variety of physiological and oncological processes through the regulation of the epigenetic modification of chromatin. However, the comprehensive Show more
The Chromobox (CBX) family members were involved in a variety of physiological and oncological processes through the regulation of the epigenetic modification of chromatin. However, the comprehensive analysis of the CBX family in head and neck squamous cell carcinoma (HNSC) is lacking. In this work, we used multiple online databases and tools to investigate the roles of CBX family in aspects of gene expression, prognostic evaluation, genetic alteration, immune micro-environment of tumor, and status of methylation. The mRNA expression levels of CBX1, CBX3, and CBX5 were aberrantly increased in patients with HNSC, while CBX7 was aberrantly decreased. Higher expression of CBX7 was significantly associated with longer OS. Within the 5-11% of genetic alteration rate of CBXs, CBX3 ranked the highest and CBX5/7 ranked the lowest. SPRR1B, S100A7, CASP14, CDSN, LCE3D were the top 5 neighbor genes with the strongest association with CBXs in HNSC patients. Signaling pathways such as epidermal cell differentiation, cornification, and peptide cross-linking were demonstrated to have a strong association with CBX genes. The profiles of immune cell infiltration had high similarity for the group of HNSC patients stratified by expression of CBXs. The methylation levels of CBX1 and CBX5 significantly decreased, while that of CBX7 significantly increased in HNSC samples when compared with normal tissue. In conclusion, the CBX family showed its valuation for further investigation in HNSC. Our research highlighted that CBX7 had the potential to be a novel diagnostic and prognostic biomarker for patients with HNSC. Show less
📄 PDF DOI: 10.2147/IJGM.S350783
CBX1
Wenjing Xiao, Jianqun Wang, Xiaojing Wang +11 more · 2022 · Autophagy · Taylor & Francis · added 2026-04-24
Macroautophagy/autophagy is a conserved cellular process associated with tumorigenesis and aggressiveness, while mechanisms regulating expression of autophagic machinery genes in cancers still remain Show more
Macroautophagy/autophagy is a conserved cellular process associated with tumorigenesis and aggressiveness, while mechanisms regulating expression of autophagic machinery genes in cancers still remain elusive. Herein, we identified E2F4 (E2F transcription factor 4) as a novel transcriptional activator of cytoprotective autophagy crucial for zinc homeostasis in cancer cells. Gain- and loss-of-function studies showed that Show less
no PDF DOI: 10.1080/15548627.2022.2044651
PIK3C3
Xiaofei Yang, Zhenghao Li, Qingfa Wang +2 more · 2022 · Cardiology in the young · added 2026-04-24
This study aims to investigate the pathogenic gene variant in a family with hypertrophic cardiomyopathy by using whole-exome sequencing and to explore the relationship between the gene variant and cli Show more
This study aims to investigate the pathogenic gene variant in a family with hypertrophic cardiomyopathy by using whole-exome sequencing and to explore the relationship between the gene variant and clinical phenotype. Peripheral blood was collected from a family with hypertrophic cardiomyopathy, and deoxyribonucleic acid was extracted. The possible pathogenic genes were detected by whole-exome sequencing, and the variant was verified by Sanger sequencing. Functional change in the variant was predicted by bioinformatics software. Clinical data of the family members are analysed simultaneously. The proband carries a novel heterozygous nonsense variant of MYBPC3:c.2731G > T (p.E911X). The analysis of amino acid conservation suggests that the variation is highly conserved. The three-dimensional protein structure shows that the variant in MYBPC3 results in the incompleteness of the fibronectintype-III2 (p872-967) domain and deletion of Ig-like C2-type 6 (p971-1065) and fibronectin type-III 3 and Ig-like C2-type 7 (p1181-1274) domains, in which p1253-1268 is predicted to have a transmembrane helix structure. Clinical data indicate that the phenotypes of variant carriers with hypertrophic cardiomyopathy are diverse, suggesting the functional damages to the protein of MYBPC3. The phenotypes of variant carriers with hypertrophic cardiomyopathy caused by the novel variant in MYBPC3: c.2731G > T (p.E911X) exhibit variable severity and clinical manifestations. Whole-exome sequencing can be used to comprehensive screen hypertrophic cardiomyopathy genes and provide a strong basis for early screening and accurate diagnosis and treatment of hypertrophic cardiomyopathy in children. Show less
no PDF DOI: 10.1017/S1047951121002468
MYBPC3
Mingyao You, Ping Yuan, Liangqian Li +1 more · 2022 · Frontiers in pharmacology · Frontiers · added 2026-04-24
📄 PDF DOI: 10.3389/fphar.2022.1066819
BACE1
Xin Zhang, Yan Deng, Jiaming Ma +7 more · 2022 · Poultry science · Elsevier · added 2026-04-24
Fatty acid composition contributes greatly to the nutritional value of meat, and breeds/strains are important factors affecting the composition of fatty acid. Recently, few studies have focused on the Show more
Fatty acid composition contributes greatly to the nutritional value of meat, and breeds/strains are important factors affecting the composition of fatty acid. Recently, few studies have focused on the fatty acid composition in breast muscle of different duck breeds. Therefore, the objective of the present study was to compare the fatty acid composition and lipid metabolism-related genes expression in breast muscle of Jianchang duck (J), Cherry Verry duck (CV) and 3 crossbred strains (BH1, BH2 and MC♂ × (BGF2♂  × GF2♀)♀ (MBG)). Our results showed that the breast muscle of J had the highest contents of C22:1(n-9) but the lowest ratios of Ʃ-omega 6 (Ʃn-6)/Ʃ-omega 3 (Ʃn-3), Ʃ-mono-unsaturated fatty acid (ƩMUFA)/Ʃ-saturated fatty acid (ƩSFA) and Ʃ-polyunsaturated fatty acid (ƩPUFA)/ƩSFA. The ƩPUFA/ƩSFA ratio was higher in breast muscle of MBG than in that of BH2 and CV, and the contents of C22:1(n-9), ƩMUFA and ƩPUFA were higher in BH1 than in BH2 and CV. Furthermore, the mRNA levels of SCD1, FADS2, ELOVL2, and ELOVL5 were significantly higher in MBG (P < 0.05), while those of FASD1 and ACACA were significantly higher in BH1 than in BH2 and CV (P < 0.05). Principal component analysis showed that fatty acids variation exhibited extensive positive loading on principal components (PCs). Correlation analysis showed that PC1 and PC3 of BH1, as well as PC1 of MBG were correlated with the mRNA levels of ACACA and FABP3, respectively. Thus, it could be concluded that the breast muscles of MBG and BH1 have better fatty acid composition, which was closely related to the increased expression levels of SCD1, FADS2, ELOVL2, and ELOVL5 genes in MBG but FADS1 and ACACA in BH1. Moreover, these results also showed that crossbreeding could optimize the composition of fatty acid in breast muscle of ducks. Show less
📄 PDF DOI: 10.1016/j.psj.2022.101813
FADS1
Xinping Li, Jingyan Yang, Ruiqi Ni +5 more · 2022 · Cell death & disease · Nature · added 2026-04-24
Breast cancer is the most common malignancy among women across the globe. Recent studies have revealed that many long non-coding RNAs (lncRNAs) regulate the Wnt/β-catenin signaling pathway in several Show more
Breast cancer is the most common malignancy among women across the globe. Recent studies have revealed that many long non-coding RNAs (lncRNAs) regulate the Wnt/β-catenin signaling pathway in several types of cancer. Hyperactivation of the Wnt/β-catenin pathway has been extensively presented in breast cancer and is involved in breast cancer progression. However, the underlying molecular mechanism remains elusive. In the current study, we found lncRNA RBM5-AS1 was remarkably upregulated in breast cancer cells and tissues. Overexpression of RBM5-AS1 facilitated proliferation, migration, invasion, EMT, and stemness maintenance of breast cancer cells in vitro and in vivo. Mechanism studies suggested that RBM5-AS1 could be transcriptionally activated by hypoxia-induced RUNX2. Upregulated RBM5-AS1 further activated the Wnt/β-catenin signaling by preventing β-catenin degradation and by helping organize β-catenin-TCF4 transcriptional complex. These findings suggested that RBM5-AS1, a regulator of Wnt/β-catenin signaling, plays a vital role in breast cancer initiation and progression, implicating its potential as a new target for breast cancer treatment. Show less
📄 PDF DOI: 10.1038/s41419-022-04536-y
AXIN1
Zhou Zhu, Liang-Feng Liu, Cheng-Fu Su +15 more · 2022 · Acta pharmacologica Sinica · Nature · added 2026-04-24
Increasing evidence shows that autophagy impairment is involved in the pathogenesis and progression of neurodegenerative diseases including Parkinson's disease (PD). We previously identified a natural Show more
Increasing evidence shows that autophagy impairment is involved in the pathogenesis and progression of neurodegenerative diseases including Parkinson's disease (PD). We previously identified a natural alkaloid named corynoxine B (Cory B) as a neuronal autophagy inducer. However, its brain permeability is relatively low, which hinders its potential use in treating PD. Thus we synthesized various derivatives of Cory B to find more potent autophagy inducers with improved brain bioavailability. In this study, we evaluated the autophagy-enhancing effect of CB6 derivative and its neuroprotective action against PD in vitro and in vivo. We showed that CB6 (5-40 μM) dose-dependently accelerated autophagy flux in cultured N2a neural cells through activating the PIK3C3 complex and promoting PI3P production. In MPP Show less
no PDF DOI: 10.1038/s41401-022-00871-0
PIK3C3
Yaodong Zhang, Zijian Ma, Changxian Li +15 more · 2022 · Nature communications · Nature · added 2026-04-24
Molecular variation between geographical populations and subtypes indicate potential genomic heterogeneity and novel genomic features within CCA. Here, we analyze exome-sequencing data of 87 perihilar Show more
Molecular variation between geographical populations and subtypes indicate potential genomic heterogeneity and novel genomic features within CCA. Here, we analyze exome-sequencing data of 87 perihilar cholangiocarcinoma (pCCA) and 261 intrahepatic cholangiocarcinoma (iCCA) cases from 3 Asian centers (including 43 pCCAs and 24 iCCAs from our center). iCCA tumours demonstrate a higher tumor mutation burden and copy number alteration burden (CNAB) than pCCA tumours, and high CNAB indicates a poorer pCCA prognosis. We identify 12 significantly mutated genes and 5 focal CNA regions, and demonstrate common mutations in post-transcriptional modification-related potential driver genes METTL14 and RBM10 in pCCA tumours. Finally we demonstrate the tumour-suppressive role of METTL14, a major RNA N6-adenosine methyltransferase (m6A), and illustrate that its loss-of-function mutation R298H may act through m6A modification on potential driver gene MACF1. Our results may be valuable for better understanding of how post-transcriptional modification can affect CCA development, and highlight both similarities and differences between pCCA and iCCA. Show less
📄 PDF DOI: 10.1038/s41467-022-30708-7
MACF1
Bo Jiang, Xiaozhi Zhao, Wei Chen +13 more · 2022 · Nature communications · Nature · added 2026-04-24
Organotropism during cancer metastasis occurs frequently but the underlying mechanism remains poorly understood. Here, we show that lysosomal protein transmembrane 5 (LAPTM5) promotes lung-specific me Show more
Organotropism during cancer metastasis occurs frequently but the underlying mechanism remains poorly understood. Here, we show that lysosomal protein transmembrane 5 (LAPTM5) promotes lung-specific metastasis in renal cancer. LAPTM5 sustains self-renewal and cancer stem cell-like traits of renal cancer cells by blocking the function of lung-derived bone morphogenetic proteins (BMPs). Mechanistic investigations showed that LAPTM5 recruits WWP2, which binds to the BMP receptor BMPR1A and mediates its lysosomal sorting, ubiquitination and ultimate degradation. BMPR1A expression was restored by the lysosomal inhibitor chloroquine. LAPTM5 expression could also serve as an independent predictor of lung metastasis in renal cancer. Lastly, elevation of LAPTM5 expression in lung metastases is a common phenomenon in multiple cancer types. Our results reveal a molecular mechanism underlying lung-specific metastasis and identify LAPTM5 as a potential therapeutic target for cancers with lung metastasis. Show less
no PDF DOI: 10.1038/s41467-022-31783-6
WWP2
Mingyuan Dong, Honghan Liu, Tianjiao Cao +4 more · 2022 · Frontiers in pharmacology · Frontiers · added 2026-04-24
Colitis-associated cancer (CAC) is a subtype of inflammatory bowel disease (IBD)-associated colorectal cancer. Huoxiang Zhengqi (HXZQ) is a classical Chinese herbal medicine and has been used to treat Show more
Colitis-associated cancer (CAC) is a subtype of inflammatory bowel disease (IBD)-associated colorectal cancer. Huoxiang Zhengqi (HXZQ) is a classical Chinese herbal medicine and has been used to treat intestinal disorders, however, anti-CAC effects and underlying mechanisms of HXZQ have not been reported. An azoxymethane/dextran sulfate sodium-induced CAC mice model was used to investigate the anti-CAC effect of HXZQ. HXZQ significantly reduced colonic inflammation, suppressed the size and number of tumors, and reduced the levels of pro-inflammatory cytokines (interleukin [IL]-1α, IL-1β, IL-6, IL-17A, IL-21, IL-23, granulocyte macrophage-colony stimulating factor, and tumor necrosis factor-α) and oxidative stress markers (reactive oxygen species and malondialdehyde), and increased the levels of anti-inflammatory cytokines (IL-10 and IL-27) in CAC mice. Intestinal microbiota and serum metabolomics analyses indicated that HXZQ altered the gut microbial composition and the abundance of 29 serum metabolites in CAC mice. Additionally, HXZQ activated the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) signaling pathway and increased the levels of antioxidants such as catalase (CAT), heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductases-1 (NQO-1), and superoxide dismutase-1 (SOD-1). HXZQ inhibited the activation of the nuclear factor kappa-B (NF-κB) signaling pathway and decreased the expression of NLR family pyrin domain containing 3 (NLRP3) by inhibiting the phosphorylation of inhibitor of nuclear factor kappa-B (IκB), inhibitor of nuclear factor kappa-B kinase (IKK), and NF-κB. In conclusion, HXZQ alleviated CAC in mice by modulating the intestinal microbiota and metabolism, activating Nrf2-mediated antioxidant response, and inhibiting NF-κB-mediated NLRP3 inflammasome activation against inflammation. The present data provide a reference for the use of HXZQ as a therapeutic or combination agent for clinical CAC treatment. Show less
📄 PDF DOI: 10.3389/fphar.2022.1002269
IL27
Xiaoxia Gong, Ning Li, Chen Sun +2 more · 2022 · Frontiers in pharmacology · Frontiers · added 2026-04-24
📄 PDF DOI: 10.3389/fphar.2022.874780
CPS1
Cong Liu, Zhuang Li, Zikuan Song +6 more · 2022 · Atherosclerosis · Elsevier · added 2026-04-24
Choline has been shown to exert atherogenic effects in Apoe Female APOE*3-Leiden.CETP mice were fed an atherogenic diet alone or supplemented with choline, butyrate or their combination for 16 weeks. Show more
Choline has been shown to exert atherogenic effects in Apoe Female APOE*3-Leiden.CETP mice were fed an atherogenic diet alone or supplemented with choline, butyrate or their combination for 16 weeks. Interestingly, choline protected against fat mass gain, increased the abundance of anti-inflammatory gut microbes, and increased the expression of gut microbial genes involved in TMA and TMAO degradation. Butyrate similarly attenuated fat mass gain and beneficially modulated the gut microbiome, as shown by increased abundance of anti-inflammatory and short chain fatty acid-producing microbes, and inhibited expression of gut microbial genes involved in lipopolysaccharide synthesis. Both choline and butyrate upregulated hepatic expression of flavin-containing monooxygenases, and their combination resulted in highest circulating TMAO levels. Nonetheless, choline, butyrate and their combination did not influence atherosclerosis development, and TMAO levels were not associated with atherosclerotic lesion size. While choline and butyrate have been reported to oppositely modulate atherosclerosis development in Apoe Show less
no PDF DOI: 10.1016/j.atherosclerosis.2022.10.009
CETP
Huiling Lai, Yunyun Guo, Liming Tian +8 more · 2022 · Cancers · MDPI · added 2026-04-24
Although ovarian cancer, a gynecological malignancy, has the highest fatality rate, it still lacks highly specific biomarkers, and the differential diagnosis of ovarian masses remains difficult to det Show more
Although ovarian cancer, a gynecological malignancy, has the highest fatality rate, it still lacks highly specific biomarkers, and the differential diagnosis of ovarian masses remains difficult to determine for gynecologists. Our study aimed to obtain ovarian cancer-specific protein candidates from the circulating small extracellular vesicles (sEVs) and develop a protein panel for ovarian cancer screening and differential diagnosis of ovarian masses. In our study, sEVs derived from the serum of healthy controls and patients with cystadenoma and ovarian cancer were investigated to obtain a cancer-specific proteomic profile. In a discovery cohort, 1119 proteins were identified, and significant differences in the protein profiles of EVs were observed among groups. Then, 23 differentially expressed proteins were assessed using the parallel reaction monitoring in a validation cohort. Through univariate and multivariate logistic regression analyses, a novel model comprising three proteins (fibrinogen gamma gene (FGG), mucin 16 (MUC16), and apolipoprotein (APOA4)) was established to screen patients with ovarian cancer. This model exhibited an area under the receiver operating characteristic curve (AUC) of 0.936 (95% CI, 0.888-0.984) with 92.0% sensitivity and 82.9% specificity. Another panel comprising serum CA125, sEV-APOA4, and sEV-CD5L showed excellent performance (AUC 0.945 (95% CI, 0.890-1.000), sensitivity of 88.0%, specificity of 93.3%, and accuracy of 89.2%) to distinguish malignancy from benign ovarian masses. Altogether, our study provided a proteomic signature of circulating sEVs in ovarian cancer. The diagnostic proteomic panel may complement current clinical diagnostic measures for screening ovarian cancer in the general population and the differential diagnosis of ovarian masses. Show less
📄 PDF DOI: 10.3390/cancers14153719
APOA4
Zhiguo Wang, Conghua Lu, Kejun Zhang +12 more · 2022 · Frontiers in molecular biosciences · Frontiers · added 2026-04-24
📄 PDF DOI: 10.3389/fmolb.2022.780200
AXIN1
Huashun Li, Dongyang Yu, Lianbing Li +9 more · 2022 · Journal of oncology · added 2026-04-24
Ovarian cancer (OC) is the most fatal gynecologic cancer. The branched-chain First, the expression level of BCKDK in OC cell lines or tissues was determined using tissue microarray- (TMA-) based immun Show more
Ovarian cancer (OC) is the most fatal gynecologic cancer. The branched-chain First, the expression level of BCKDK in OC cell lines or tissues was determined using tissue microarray- (TMA-) based immunohistochemistry or western blotting. Then, growth curve analysis, anchorage-independent cell transformation assays, wound healing assays, cell migration assays, and tumor xenografts were used to test whether BCKDK could promote cell transformation or metastasis. Finally, the signaling pathways involved in this process were investigated by western blotting or immunoprecipitation. We found that the expression of BCKDK was upregulated in OC tissues and the high expression of BCKDK was correlated with an advanced pathological grade in patients. The ectopic overexpression of BCKDK promoted the proliferation and migration of OC cells, and the knockdown of BCKDK with shRNAs inhibited the proliferation and migration of OC ex vivo and Our results demonstrate that BCKDK promotes OC proliferation and migration by activating the MEK/ERK signaling pathway. Targeting the BCKDK-MEK axis may provide a new therapeutic strategy for treating patients with OC. Show less
📄 PDF DOI: 10.1155/2022/3691635
BCKDK
Jiannan Li, Ruibin Wang, Qiang Chen +3 more · 2022 · Theriogenology · Elsevier · added 2026-04-24
An optimal lipid droplet (LD) content is essential for successful mammalian embryonic development. Salidroside (SAL) is a traditional Chinese medicine and one of the important active components of the Show more
An optimal lipid droplet (LD) content is essential for successful mammalian embryonic development. Salidroside (SAL) is a traditional Chinese medicine and one of the important active components of the Rhodiola plant. SAL possesses antioxidative, anti-aging, and cardiovascular properties. Here, we studied the effects of SAL on in vitro maturation (IVM) of porcine oocytes and the subsequent embryonic development after parthenogenetic activation (PA). We found that 100 μM of SAL had no effect on the extrusion rate of the first polar body of porcine oocytes but significantly improved the subsequent blastocyst formation rate and embryo quality. Our study further revealed that SAL treatment altered the morphology, increased the lipid content in oocytes, increased mitochondrial number. Further analysis revealed that SAL upregulated the expression of genes related to lipid metabolism (FASN, FADS1, HSL, and CPT1a) and the mitochondria function-related genes (PGC-1α). These results suggest that SAL supplementation enhances oocyte maturation and subsequent embryonic development by promoting lipid metabolism, providing the necessary energy for the aforementioned processes. Show less
no PDF DOI: 10.1016/j.theriogenology.2022.08.028
FADS1
Linshuang Wang, Xiaoyu Xu, Zikang Wang +8 more · 2022 · Evidence-based complementary and alternative medicine : eCAM · added 2026-04-24
Traditional Chinese herbal medicine draws more attention to explore an effective therapeutic strategy for Alzheimer's disease (AD). Shenqi Yizhi granule (SQYG), a Chinese herbal recipe, has been appli Show more
Traditional Chinese herbal medicine draws more attention to explore an effective therapeutic strategy for Alzheimer's disease (AD). Shenqi Yizhi granule (SQYG), a Chinese herbal recipe, has been applied to ameliorate cognitive impairment in mild-to-moderate AD patients. However, the overall molecular mechanism of SQYG in treating AD has not been clarified. This study aimed to investigate the molecular mechanism of SQYG on AD using an integration strategy of network pharmacology and molecular docking. The active compounds of SQYG and common targets between SQYG and AD were screened from databases. The herb-compound network, compound-target network, and protein-protein interaction network were constructed. The enrichment analysis of common targets and molecular docking were performed. 816 compounds and 307 common targets between SQYG and AD were screened. KEGG analysis revealed that common targets were mainly enriched in lipid metabolism, metal ion metabolism, IL-17 signaling pathway, GABA receptor signaling, and neuroactive ligand-receptor interaction. Molecular docking analysis showed high binding affinity between ginsenoside Rg1 and A The therapeutic mechanisms of SQYG on AD were associated with regulating lipid metabolism, metal ion metabolism, IL-17 signaling pathway, and GABA receptor signaling. Ginsenoside Rg1, tanshinone IIA, baicalin, astragaloside IV, and folic acid may play an important role in AD treatment. Show less
📄 PDF DOI: 10.1155/2022/8032036
BACE1
Hanying Wang, Xin He, Lei Zhang +26 more · 2022 · Blood · added 2026-04-24
Differentiation blockade is a hallmark of acute myeloid leukemia (AML). A strategy to overcome such a blockade is a promising approach against the disease. The lack of understanding of the underlying Show more
Differentiation blockade is a hallmark of acute myeloid leukemia (AML). A strategy to overcome such a blockade is a promising approach against the disease. The lack of understanding of the underlying mechanisms hampers development of such strategies. Dysregulated ribonucleotide reductase (RNR) is considered a druggable target in proliferative cancers susceptible to deoxynucleoside triphosphate (dNTP) depletion. Herein, we report an unanticipated discovery that hyperactivating RNR enables differentiation and decreases leukemia cell growth. We integrate pharmacogenomics and metabolomics analyses to identify that pharmacologically (eg, nelarabine) or genetically upregulating RNR subunit M2 (RRM2) creates a dNTP pool imbalance and overcomes differentiation arrest. Moreover, R-loop-mediated DNA replication stress signaling is responsible for RRM2 activation by nelarabine treatment. Further aggravating dNTP imbalance by depleting the dNTP hydrolase SAM domain and HD domain-containing protein 1 (SAMHD1) enhances ablation of leukemia stem cells by RRM2 hyperactivation. Mechanistically, excessive activation of extracellular signal-regulated kinase (ERK) signaling downstream of the imbalance contributes to cellular outcomes of RNR hyperactivation. A CRISPR screen identifies a synthetic lethal interaction between loss of DUSP6, an ERK-negative regulator, and nelarabine treatment. These data demonstrate that dNTP homeostasis governs leukemia maintenance, and a combination of DUSP inhibition and nelarabine represents a therapeutic strategy. Show less
no PDF DOI: 10.1182/blood.2021015108
DUSP6
Ruo-Xin Zhang, Sha-Sha Li, An-Qi Li +3 more · 2022 · Life (Basel, Switzerland) · MDPI · added 2026-04-24
Many studies show that genetics play a major contribution to the onset of obesity. Human genome-wide association studies (GWASs) have identified hundreds of genes that are associated with obesity. How Show more
Many studies show that genetics play a major contribution to the onset of obesity. Human genome-wide association studies (GWASs) have identified hundreds of genes that are associated with obesity. However, the majority of them have not been functionally validated. Show less
no PDF DOI: 10.3390/life13010081
SEC16B
Lijie Wu, Jinku Li, Lili Ping +4 more · 2022 · Evidence-based complementary and alternative medicine : eCAM · added 2026-04-24
To explore the diagnosis value of inflammatory markers and cytokines in neonatal sepsis. In this retrospective analysis, 90 cases of neonatal sepsis admitted to our hospital from April 2019 to April 2 Show more
To explore the diagnosis value of inflammatory markers and cytokines in neonatal sepsis. In this retrospective analysis, 90 cases of neonatal sepsis admitted to our hospital from April 2019 to April 2021 were included in the observation group, and 70 healthy neonates who received routine physical examinations in our hospital during the same period were recruited as the control group. Comparison and analysis of inflammatory markers and cytokines levels between the two groups were performed on days 1, 3, and 7 after the onset. Flow cytometry was used to measure the white blood cells (WBCs) and percentage of neutrophils (N%), immunoturbidimetry was used to determine C-reactive protein (CRP), immunochromatographic analysis was used to determine procalcitonin (PCT) in plasma, and the enzyme-linked immunosorbent assay was used to determine interleukin-27 (IL-27), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor- Compared with healthy controls, neonatal sepsis resulted in significantly higher levels of WBC, N%, PCT, and CRP on days 1, 3, and 7 after onset. The levels of WBC, N%, and PCT were continuously decreased from day 1 to day 7, while the levels of CRP were increased on day 1 and day 3 but declined on day 7 ( Neonatal sepsis was associated with fluctuating levels of WBC, N%, PCT, CRP, IL-27, IL-6, IL-10, and TNF- Show less
📄 PDF DOI: 10.1155/2022/4143101
IL27
Dong Cheng, Shengye Zhang, Xiaowei Li +3 more · 2022 · Stem cell research · Elsevier · added 2026-04-24
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease often caused by sarcomeric gene mutations. MYBPC3 is one of the most common genes associated with HCM. In this study, we ge Show more
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease often caused by sarcomeric gene mutations. MYBPC3 is one of the most common genes associated with HCM. In this study, we generated a human induced pluripotent stem cell line ZZUNEUi028-A from a 19-year-old male HCM patient with c. 1504C → T in MYBPC3 gene using non-integrative Sendai viral reprogramming technology. This cell line expresses pluripotency markers, exhibits a normal male karyotype (46, XY) and can differentiate into all three germ layers in vitro. ZZUNEUi028-A can serve as a cell disease model in the understanding of HCM pathogenesis. Show less
no PDF DOI: 10.1016/j.scr.2022.102848
MYBPC3
Mengyao Shi, Tanika N Kelly, Zhengbao Zhu +16 more · 2022 · Journal of the American Heart Association · added 2026-04-24
Background Ischemic stroke is likely caused by interactions of multiple genes and environmental determinants. However, large-scale sequencing studies to discern functional genetic variants and their i Show more
Background Ischemic stroke is likely caused by interactions of multiple genes and environmental determinants. However, large-scale sequencing studies to discern functional genetic variants and their interactions with clinical and lifestyle risk factors on ischemic stroke are limited. Methods and Results We sequenced functional regions of 740 previously identified genes associated with atherosclerotic disease among 999 ischemic stroke cases and 1001 controls of Chinese ancestry. Multiple logistic regression models were used to examine the associations between variants and ischemic stroke and test interactions between variants and clinical and lifestyle risk factors. Functional variants achieving suggestive significance were replicated in an independent sample of 4724 ischemic stroke cases and 5029 controls. Driven by variant main effects, each minor allele of the correlated rs174535, rs174545, and rs3834458 variants at Show less
📄 PDF DOI: 10.1161/JAHA.122.025245
FADS1
Chun-Yan Hu, Xuan Li, Tian Zeng +3 more · 2022 · Gene · Elsevier · added 2026-04-24
Diffuse large B-cell lymphoma (DLBCL) is the main pathological type of non-Hodgkin lymphoma (NHL). Chromobox (CBX) family proteins are classical components of polycomb group (PcG) complexes in many ca Show more
Diffuse large B-cell lymphoma (DLBCL) is the main pathological type of non-Hodgkin lymphoma (NHL). Chromobox (CBX) family proteins are classical components of polycomb group (PcG) complexes in many cancer types, resulting in accelerated carcinogenesis. Nevertheless, the prognostic, functional and expression significance of these CBX family members in DLBCL remain unclear and elusive. CBX transcriptional levels were confirmed using Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA) and Cancer Cell Line Encyclopedia (CCLE) databases. The protein levels of CBX family members were analysed using The Human Protein Atlas (HPA) database. Information on the PPI network, functional enrichment, drug sensitivity, prognostic value, miRNA network, protein structure, genetic alteration and immune cell infiltration were generated using the GeneMANIA, Metascape, GSCALite, GEPIA, PDB, cBioPortal, and TIMER databases, and the correlation of these factors with CBX expression levels in DLBCL was assessed. CBX1/2/3/5/6/8 mRNA levels were significantly enhanced in DLBCL tissues compared to corresponding normal tissues. CBX1/3/4/5/8 protein expression levels were obviously increased, whereas CBX7 was obviously decreased. This difference might be attributed to miRNA regulation based on the miRNA network. Overall survival (OS) analysis showed that CBX levels were not correlated with prognosis in DLBCL patients, indicating that CBXs are not good biomarkers for DLBCL patients. Furthermore, functional enrichment analyses indicated that CBXs were closely related to DNA duplex unwinding, covalent chromatin modification, and histone lysine methylation. The levels of CBXs were also significantly associated with diverse immune cell infiltration in DLBCL. This study reveals that dysregulated CBXs are involved in DLBCL development and might represent potential therapeutic targets for DLBCL. Show less
no PDF DOI: 10.1016/j.gene.2021.146092
CBX1